A detailed history of Cwm, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 10,992 shares of HRTX stock, worth $11,761. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,992
Previous 4,066 170.34%
Holding current value
$11,761
Previous $14,000 57.14%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$1.73 - $3.67 $11,981 - $25,418
6,926 Added 170.34%
10,992 $22,000
Q2 2024

Jul 09, 2024

BUY
$2.32 - $3.86 $9,412 - $15,660
4,057 Added 45077.78%
4,066 $14,000
Q1 2024

Apr 05, 2024

BUY
$1.71 - $3.06 $15 - $27
9 New
9 $0
Q2 2023

Aug 03, 2023

SELL
$1.11 - $2.88 $74 - $192
-67 Reduced 12.96%
450 $1,000
Q1 2023

Apr 28, 2023

SELL
$1.51 - $3.25 $1,355 - $2,918
-898 Reduced 63.46%
517 $1,000
Q4 2022

Feb 01, 2023

SELL
$2.25 - $4.67 $978 - $2,031
-435 Reduced 23.51%
1,415 $4,000
Q2 2022

Jul 28, 2022

SELL
$2.3 - $6.29 $299 - $817
-130 Reduced 6.57%
1,850 $5,000
Q1 2022

Apr 21, 2022

BUY
$4.63 - $9.94 $7,083 - $15,208
1,530 Added 340.0%
1,980 $11,000
Q4 2020

Sep 15, 2021

BUY
$14.61 - $22.14 $6,574 - $9,963
450 New
450 $7,000
Q4 2020

Jan 27, 2021

SELL
$14.61 - $22.14 $6,574 - $9,963
-450 Closed
0 $0
Q3 2020

Sep 15, 2021

BUY
$13.67 - $17.77 $6,151 - $7,996
450 New
450 $7,000
Q3 2020

Oct 19, 2020

SELL
$13.67 - $17.77 $6,151 - $7,996
-450 Closed
0 $0
Q2 2020

Sep 15, 2021

SELL
$10.89 - $21.47 $7,623 - $15,029
-700 Reduced 60.87%
450 $7,000
Q2 2020

Jul 22, 2020

BUY
$10.89 - $21.47 $7,623 - $15,029
700 Added 155.56%
1,150 $17,000
Q1 2020

Sep 15, 2021

SELL
$10.23 - $24.56 $7,161 - $17,192
-700 Reduced 60.87%
450 $7,000
Q1 2020

Apr 28, 2020

BUY
$10.23 - $24.56 $7,161 - $17,192
700 Added 155.56%
1,150 $14,000
Q4 2019

Sep 14, 2021

SELL
$17.42 - $26.61 $13,692 - $20,915
-786 Reduced 63.59%
450 $7,000
Q4 2019

Jan 27, 2020

BUY
$17.42 - $26.61 $13,692 - $20,915
786 Added 174.67%
1,236 $29,000
Q3 2019

Sep 14, 2021

SELL
$16.36 - $21.39 $11,452 - $14,973
-700 Reduced 60.87%
450 $7,000
Q3 2019

Oct 22, 2019

BUY
$16.36 - $21.39 $11,452 - $14,973
700 Added 155.56%
1,150 $21,000
Q2 2019

Sep 14, 2021

SELL
$16.93 - $26.22 $3,386 - $5,244
-200 Reduced 30.77%
450 $7,000
Q2 2019

Jul 31, 2019

BUY
$16.93 - $26.22 $3,386 - $5,244
200 Added 44.44%
650 $12,000
Q1 2019

Sep 02, 2021

SELL
$23.15 - $28.34 $4,630 - $5,668
-200 Reduced 30.77%
450 $0
Q1 2019

Apr 22, 2019

BUY
$23.15 - $28.34 $15,047 - $18,421
650 New
650 $16,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $127M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.